- Home
- VRSN vs PODD Comparison
VRSN vs PODD Comparison
Compare VRSN & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRSN
- PODD
- Stock Information
- Founded
- VRSN 1995
- PODD 2000
- Country
- VRSN United States
- PODD United States
- Employees
- VRSN N/A
- PODD N/A
- Industry
- VRSN EDP Services
- PODD Medical/Dental Instruments
- Sector
- VRSN Technology
- PODD Health Care
- Exchange
- VRSN Nasdaq
- PODD Nasdaq
- Market Cap
- VRSN 27.1B
- PODD 22.1B
- IPO Year
- VRSN 1998
- PODD 2007
- Fundamental
- Price
- VRSN $246.39
- PODD $322.10
- Analyst Decision
- VRSN Strong Buy
- PODD Strong Buy
- Analyst Count
- VRSN 2
- PODD 19
- Target Price
- VRSN $277.50
- PODD $338.79
- AVG Volume (30 Days)
- VRSN 913.2K
- PODD 537.2K
- Earning Date
- VRSN 10-23-2025
- PODD 11-06-2025
- Dividend Yield
- VRSN 1.25%
- PODD N/A
- EPS Growth
- VRSN N/A
- PODD N/A
- EPS
- VRSN 8.58
- PODD 3.32
- Revenue
- VRSN $1,626,700,000.00
- PODD $2,359,500,000.00
- Revenue This Year
- VRSN $8.13
- PODD $29.18
- Revenue Next Year
- VRSN $2.97
- PODD $18.16
- P/E Ratio
- VRSN $28.80
- PODD $96.58
- Revenue Growth
- VRSN 5.47
- PODD 26.00
- 52 Week Low
- VRSN $175.62
- PODD $226.50
- 52 Week High
- VRSN $310.60
- PODD $353.50
- Technical
- Relative Strength Index (RSI)
- VRSN 26.21
- PODD 50.50
- Support Level
- VRSN $259.63
- PODD $312.05
- Resistance Level
- VRSN $269.47
- PODD $335.26
- Average True Range (ATR)
- VRSN 7.92
- PODD 7.56
- MACD
- VRSN -1.86
- PODD 1.58
- Stochastic Oscillator
- VRSN 44.98
- PODD 47.74
About VRSN VeriSign Inc.
VeriSign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.